I dont disagree. They have the US market cornered by being the only FDA approved cannabis medicine...and a year supply costs something like $30K. I listen to so many podcasts and not only do MSO investors want cannabis descheduled but also researchers (university researchers). They want to investigate the plant (and dispensary grade quality, not UMISS product), but because of it's schedule 1 status they (A) cant get govt funding to do so, but also (B) can't bring the plant on campus. That is why I think the most likely next step is to get the research bill approved. It was only being held up because a politician was upset none of his 'bills' were getting attention. I think that is the next logical catalyst...and the first cannabis bill Biden signs.